~~<i id='C450A179F1'><strike id='C450A179F1'><tt id='C450A179F1'><pre id='C450A179F1'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

entertainment

author：comprehensive 2025-09-27 09:59:14 - browse：77791

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Arena BioWorks launches in Cambridge to speed drug discovery

knowledge

entertainment

explore

knowledge

explore

leisure time

2:30ResidentspassalongastreetinNikopol,withtheZaporizhzhiaNuclearPowerPlantinthebackground,behindane

WSS

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Drinking water from half of US faucets contains PFAS: Study

Medicare Advantage overpayments discussion gets experts fired up

FDA approves Leqembi, a milestone in Alzheimer’s treatment

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

Boston Scientific acquires urology company Axonics for $3.7 billion

focus

entertainment

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

Medical records are filled with copy

Medicare Advantage coverage denials need scrutiny, senators say

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Masked men burn a market in a Mexican city plagued by gang violence, killing 9 people

Jerome Adams on the need for new antivirals for Covid

The PBM ad wars are taking over Washington, D.C.

Apple is now the first public company to be valued at $3 trillion

Rare Northern Lights show in US this week: Where and how to see it

entertainment

Does Paxlovid work in people vaccinated against Covid

Another man arrested in connection with shooting at Kansas nightclub

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

At JPM 2024, hospital systems pitch financial strength to investors

Rare Northern Lights show in US this week: Where and how to see it

explore

knowledge

explore

leisure time